您好,欢迎访问山东省农业科学院文献资源数据库平台

Novel compounds with promising IDO1 inhibitory activity as new cancer drug candidates: Derivatives of N,N'-diphenylurea linked with 1,2,3-triazole

文献类型: 外文期刊

作者: Sun, Bin 1 ; Liu, Xiaofei 2 ; Sun, Xiuwei 2 ; Zhou, Yingjie 4 ; Gong, Xiaoqing 5 ; Mao, Longfei 2 ; Shi, Weichen 2 ; Deng, Peng 2 ; Shi, Lin 7 ;

作者机构: 1.Shandong NormColl Chem Chem Engn & Mat Sci, Collaborat Innovat Ctr Functionalized Probes Chem, Shandong Prov Key Lab Clean Prod Fine Chemicalsal, Key Lab Mol & Nano Probes,Minist Educ, Jinan, Peoples R China

2.Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agroprod Proc Technol Shandong Prov, Key Lab Novel Food Resources Proc,Minist Agr, Jinan 250100, Peoples R China

3.Jinan Asia Pharm Tech Co Ltd, Jinan, Peoples R China

4.Henan Normal Univ, Sch Chem & Chem Engn, Xinxiang, Peoples R China

5.Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou, Peoples R China

6.Shandong First Med Univ, Dept Thyroid Surg, Affiliated Hosp 1, Jinan, Peoples R China

7.Shandong First Med Univ, Dept Ultrasound Diag, Shandong Prov Hosp, Jinan, Peoples R China

8.Shandong First Med Univ, Shandong Prov Hosp, Treatment Dept, Jinan 250021, Peoples R China

期刊名称:PHARMAZIE ( 影响因子:1.6; 五年影响因子:1.6 )

ISSN: 0031-7144

年卷期: 2023 年 78 卷 1-4 期

页码:

收录情况: SCI

摘要: To explore potential indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors, we designed a series of compounds incorporating urea and 1,2,3-triazole structures. IDO1 enzymatic activity experiments with the synthesized compounds were used to verify their molecular-level activity; for instance, the half maximal inhibitory concentra-tion value of compound 3c was 0.07 mu M. Our research has yielded a series of novel IDO1 inhibitors which may be beneficial in the development of drugs targeting IDO1 for cancer treatment.

  • 相关文献
作者其他论文 更多>>